Authors:
Tortora, G
Caputo, R
Damiano, V
Bianco, R
Fontanini, G
Cuccato, S
De Placido, S
Bianco, AR
Ciardiello, F
Citation: G. Tortora et al., Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis, CLIN CANC R, 7(8), 2001, pp. 2537-2544
Authors:
Ciardiello, F
Caputo, R
Bianco, R
Damiano, V
Fentanini, G
Cuccato, S
De Placido, S
Bianco, AR
Tortora, G
Citation: F. Ciardiello et al., Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor, CLIN CANC R, 7(5), 2001, pp. 1459-1465
Authors:
Ciardiello, F
Bianco, R
Damiano, V
Fontanini, G
Caputo, R
Pomatico, G
De Placido, S
Bianco, AR
Mendelsohn, J
Tortora, G
Citation: F. Ciardiello et al., Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells, CLIN CANC R, 6(9), 2000, pp. 3739-3747
Authors:
Tortora, G
Bianco, R
Damiano, V
Fontanini, G
De Placido, S
Bianco, AR
Ciardiello, F
Citation: G. Tortora et al., Oral antisense that targets protein kinase A cooperates with taxol and inhibits tumor growth, angiogenesis, and growth factor production, CLIN CANC R, 6(6), 2000, pp. 2506-2512
Authors:
Ciardiello, F
Caputo, R
Bianco, R
Damiano, V
Pomatico, G
De Placido, S
Bianco, AR
Tortora, G
Citation: F. Ciardiello et al., Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor, CLIN CANC R, 6(5), 2000, pp. 2053-2063
Authors:
Bianco, C
Bianco, R
Tortora, G
Damiano, V
Guerrieri, P
Montemaggi, P
Mendelsohn, J
De Placido, S
Bianco, AR
Ciardiello, F
Citation: C. Bianco et al., Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide, CLIN CANC R, 6(11), 2000, pp. 4343-4350
Authors:
Perrone, F
Daniele, B
Gaeta, GB
Pignata, S
Gallo, C
Izzo, F
Cuomo, O
Capuano, G
Ruggiero, G
Mazzanti, R
Farinati, F
Elba, S
Daniele, B
Pignata, S
Cremona, F
Izzo, F
Parisi, V
Fiore, F
Vallone, P
Perrone, F
Cuomo, O
Di Palma, M
Manno, E
Militerno, G
Budillon, G
Capuano, G
Cimino, L
Pomponi, D
Adinolfi, LE
Ragone, E
Ruggiero, G
Utili, R
Arena, U
Di Fiore, G
Gentilini, P
Mazzanti, R
Farinati, F
Rinaldi, M
Elba, S
Coviello, A
Manghisi, OG
Crispino, B
Laviscio, R
Piaib, G
Caporaso, N
De Sio, I
Belli, G
Iannelli, A
Santangelo, ML
Gaeta, GB
Ascione, T
Giusti, G
D'Angelo, V
Francica, G
Marone, G
Pasquale, G
Piccinino, F
Stanzione, M
Bianco, AR
De Placido, S
Palmieri, G
D'Agostino, L
Mattera, D
Puzziello, A
Aiello, A
Ferrau, O
Freni, MA
Aloisio, V
Giorgio, A
Perrotta, A
Calandra, M
Castellano, L
Blanco, CD
Castiglione, F
Mazzacca, G
Rispo, A
Colurcio, R
Galanti, B
Russo, M
Palmentieri, B
Persico, M
Felder, M
Zancanella, L
Belli, M
Colantuoni, G
De Sena, G
Guardascione, F
Petrelli, G
Lamorgese, B
Manzione, L
Pedicini, T
D'Aprile, M
Gallo, C
Citation: F. Perrone et al., Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma, HEPATOLOGY, 31(4), 2000, pp. 840-845
Authors:
De Placido, S
Tramontana, S
Ferrari, E
De Matteis, A
Lauria, R
Perrone, F
Bianco, AR
Gallo, C
Ricchi, P
De Placido, G
Pignata, S
Citation: S. De Placido et al., Carboplatin, cisplatin and paclitaxel in the treatment of patients with epithelial ovarian cancer, ANTICANC R, 20(5C), 2000, pp. 4023-4029
Authors:
De Placido, S
Lauria, R
Perrone, F
Lombardi, AV
Carlomagno, C
Varriale, E
Costanzo, R
Leo, L
De Laurentiis, M
Bianco, AR
Citation: S. De Placido et al., Vinorelbine plus mitomycin C as second-line treatment of metastatic breastcancer: A two-stage phase 2 study, ONCOL-BASEL, 58(1), 2000, pp. 8-14
Authors:
Ciardiello, F
Caputo, R
Pomatico, G
De Laurentiis, M
De Placido, S
Bianco, AR
Tortora, G
Citation: F. Ciardiello et al., Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase A, INT J CANC, 85(5), 2000, pp. 710-715
Authors:
Pepe, S
Ruggiero, A
D'Acquisto, M
De Laurentiis, M
De Placido, S
Sandomenico, C
Staibano, S
De Rosa, G
Lucariello, A
D'Armiento, M
Bianco, AR
Citation: S. Pepe et al., Nuclear DNA content-derived parameters correlated with heterogeneous expression of p53 and bcl-2 proteins in clear cell renal carcinomas, CANCER, 89(5), 2000, pp. 1065-1075
Authors:
Ciardiello, F
Bianco, R
Damiano, V
De Lorenzo, S
Pepe, S
De Placido, S
Fan, Z
Mendelsohn, J
Bianco, AR
Tortora, G
Citation: F. Ciardiello et al., Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225, CLIN CANC R, 5(4), 1999, pp. 909-916
Authors:
De Laurentiis, M
De Placido, S
Bianco, AR
Clark, GM
Ravdin, PM
Citation: M. De Laurentiis et al., A prognostic model that makes quantitative estimates of probability of relapse for breast cancer patients, CLIN CANC R, 5(12), 1999, pp. 4133-4139
Authors:
De Placido, S
Carlomagno, C
Ciardiello, F
De Laurentiis, M
Pepe, S
Ruggiero, A
Tortora, G
Panico, L
D'Antonio, A
Pettinato, G
Petrella, G
Bianco, AR
Citation: S. De Placido et al., Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-term follow-up, CLIN CANC R, 5(10), 1999, pp. 2854-2859
Authors:
De Placido, S
Lauria, R
Carlomagno, C
Perrone, F
De Laurentiis, M
Gallo, C
Martignetti, A
Bellelli, T
Limite, G
Petrella, G
Bianco, AR
Citation: S. De Placido et al., The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer, INT J ONCOL, 15(2), 1999, pp. 339-346
Authors:
Lauria, R
Ferrari, E
Tramontana, S
Morabito, A
Perrone, F
Maffeo, A
Fiorentino, R
Casella, G
Iodice, F
Ricchi, P
Carlomagno, C
Varriale, E
De Placido, G
De Placido, S
Bianco, AR
Pignata, S
Citation: R. Lauria et al., A phase I study of paclitaxel and epirubicin, without and with filgrastim,for the treatment of platinum-resistant advanced ovarian cancer, ONCOL-BASEL, 56(4), 1999, pp. 267-273